By 2023, the spinal injectable market sales is expected to be valued US$ 23.3 billion. By 2033, the market is expected to have grown to around US$ 51.2 billion, with a compound annual growth rate of 8.2%. As chronic lower back pain grows more common, the global market for spinal injectables is predicted to increase …
Continue reading “Spinal Injectable Market Poised for a US$ 51.2 Billion Surge by 2033”